AFRM
Affirm Holdings, Inc.
AFRM's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over AFRM overall, supported by stronger valuation and stronger modeled upside.
AFRM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
AFRM's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
AFRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 11x | $65.84 | — |
| Cheap | 14x | $82.33 | +25% |
| Forward | 30x | $65.84 | — |
| Fair | 68x | $393 | +497% |
| Expensive | 113x | $651 | +889% |
Historical ranges are pointers, not guarantees.
AFRM has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
AFRM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for AFRM, with profitability improving. However, they disagree widely on these estimates.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over AFRM on the outlook, with more favorable valuation expectations.
AFRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.20 | -62% |
| Q3 2026 | $5.77 | +736% |
| Q2 2026 | $5.53 | +3587% |
| Q1 2026 | $1.12 | +$1.32 |
| Q4 2025 | $0.83 | +$1.47 |
| Q3 2025 | $0.69 | +$2.10 |
| Q2 2025 | $0.15 | +$1.82 |
| Q1 2025 | -$0.20 | +$2.03 |
| Q4 2024 | -$0.64 | +$1.85 |
AFRM's earnings per share have climbed steadily: $5.77 over the past year, about eight times what it earned the year before, and higher year over year for 12 quarters in a row. Its recent earnings include one-off gains.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU's earnings per share have climbed steadily: $74.33 over the past year, about 10 times what it earned the year before, and higher year over year for 10 quarters in a row.
AFRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +35% |
| Q2 2026 | $1.2B | +33% |
| Q1 2026 | $1B | +33% |
| Q4 2025 | $1.1B | +30% |
| Q3 2025 | $933.3M | +34% |
| Q2 2025 | $876.4M | +33% |
| Q1 2025 | $783.1M | +36% |
| Q4 2024 | $866.4M | +47% |
AFRM's revenue has grown year over year every quarter since late 2020: $1.3B last quarter, up 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +8 points |
| Q2 2026 | 13% | +6 points |
| Q1 2026 | 8.5% | +9.6 points |
| Q4 2025 | 10% | +11 points |
| Q3 2025 | 6.8% | +26 points |
| Q2 2025 | 6.6% | +18 points |
| Q1 2025 | -1.1% | +27 points |
| Q4 2024 | -0.5% | +29 points |
AFRM's operating margin was 15% last quarter, up 8 points from the same quarter a year ago, near the top of its range since 2019.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over AFRM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over AFRM on profitability, with a higher operating margin.
AFRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $144.6M | -55% |
| Q2 2026 | $229.3M | +875% |
| Q1 2026 | $325.1M | +107% |
| Q4 2025 | $118M | -56% |
| Q3 2025 | $320.2M | +110% |
| Q2 2025 | $23.5M | -23% |
| Q1 2025 | $157.4M | -2.7% |
| Q4 2024 | $268.1M | +654% |
AFRM generated $817M in free cash flow over the past year, up 6.2% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over AFRM on cash flow, with more consistent year-over-year improvement.
AFRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +2.9M shares |
| 1 year | +1% | +3.5M shares |
| 3 years | +16% | +47.9M shares |
| 5 years | +29% | +80.1M shares |
| Available history | +68% | +142M shares |
AFRM has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
AFRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.5x | High |
| Q2 2026 | 11.3x | High |
| Q1 2026 | 11.8x | High |
| Q4 2025 | 15.1x | High |
| Q3 2025 | 17.9x | High |
| Q2 2025 | 45.4x | High |
| Q1 2025 | 755.3x | High |
AFRM's net debt is about 9.5 years of its operating earnings (EBITDA), down from 18 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over AFRM on leverage, with a lower net debt burden relative to earnings.
AFRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.8 | Neutral |
| Stochastic | 14.7 | Oversold |
AFRM's weekly RSI is 45 (neutral) and its Stochastic is 15 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
AFRM PE vs Technology Sector
| Metric | AFRM | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 59% below |
| PE % | 0 | 40 | 40 pts below |
AFRM is trading at 11x earnings, a 59% discount to the Technology sector's median of 28x, though its earnings don't support one.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over AFRM on valuation relative to its sector.
AFRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.8 | 8.3% below |
| 20 week MA | $74.2 | 11% below |
| 50 week MA | $67.3 | 2.2% below |
| 100 week MA | $65.8 | 0% above |
| 200 week MA | $47.4 | 39% above |
AFRM has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 39% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over AFRM on trend strength, trading above more of its moving averages.
AFRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $117.0 | $101.2 | -14% |
| 2022 | $101.2 | $9.19 | -91% |
| 2023 | $9.19 | $49.1 | +435% |
| 2024 | $49.1 | $64.6 | +32% |
| 2025 | $64.6 | $75.8 | +17% |
| 2026 YTD | $75.8 | $65.8 | -13% |
AFRM's yearly returns have swung widely, from +435% in 2023 to −91% in 2022. It's down 13% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over AFRM on returns for 2026, with the stronger performance.